価格表

在庫・価格 : 2024年05月18日 07時51分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
pNF-H, Human, ELISA Kit (96well) <Phosphorylated Neurofilament H, ELISA Kit>
データシート
RD191138300R BLMバイオベンダー ラボラトリー
BioVendor Laboratory Medicine, Inc.
1 kit ¥132,000
(未発注)
追加

在庫・価格 : 2024年05月18日 07時51分 現在

pNF-H, Human, ELISA Kit (96well) <Phosphorylated Neurofilament H, ELISA Kit>

  • 商品コード:RD191138300R
  • メーカー:BLM
  • 包装:1kit
  • 価格: ¥132,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Zurek J et al. Hyperphosphorylated neurofilament NF-H as a predictor of mortality after brain injury in children. Brain Inj 2011;25(2):221-6
Zurek J et al
2011/01/01
PubMed
2 Cai JY et al. Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage. Clin. Chim. Acta 2013 Sep;424:182-6
Cai JY et al
2013/01/01
PubMed
3 Chen X et al. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis. BMC Neurol 2016 Sep;16:173
Chen X et al
2016/01/01
PubMed
4 Denk J et al. Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls. PLoS ONE 2018;13(5):e0197329
Denk J et al
2018/01/01
PubMed
5 Fialov叩 L et al. Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis. J. Neuroimmunol. 2013 Jun;259(1-2):81-7
Fialov叩 L et al
2013/01/01
PubMed
6 Ganesalingam J et al. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J. Neurochem. 2011 May;117(3):528-37
Ganesalingam J et al
2011/01/01
PubMed
7 Gon巽alves M et al. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis. Clin. Chim. Acta 2015 Jan;438:342-9
Gon巽alves M et al
2015/01/01
PubMed
8 Gresle MM et al. Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis. Mult Scler Int 2011;2011:315406
Gresle MM et al
2011/01/01
PubMed
9 Inoue R et al. Direct evidence of central nervous system axonal damage in patients with postoperative delirium: A preliminary study of pNF-H as a promising serum biomarker. Neurosci. Lett. 2017 Jul;653:39-44
Inoue R et al
2017/01/01
PubMed
10 Kuwajima K et al. Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study. PLoS ONE 2018;13(11):e0207310
Kuwajima K et al
2018/01/01
PubMed
11 Lehmer C et al. Poly-GP in cerebrospinal fluid links <i>C9orf72</i>-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD. EMBO Mol Med 2017 07;9(7):859-868
Lehmer C et al
2017/01/01
PubMed
12 Li S et al. Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis. J. Neurol. Sci. 2016 Aug;367:269-74
Li S et al
2016/01/01
PubMed
13 McGuire JL et al. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J. Neurovirol. 2015 Aug;21(4):439-48
McGuire JL et al
2015/01/01
PubMed
14 Natori A et al. Potential role of pNF-H, a biomarker of axonal damage in the central nervous system, as a predictive marker of chemotherapy-induced cognitive impairment. Clin. Cancer Res. 2015 Mar;21(6):1348-52
Natori A et al
2015/01/01
PubMed
15 Pawliszak W et al. Three-vessel coronary artery disease may predict changes in biochemical brain injury markers after off-pump coronary artery bypass grafting<sup></sup>. J Zhejiang Univ Sci B ;19(9):735-738
Pawliszak W et al
PubMed
16 Pironkova RP et al. Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery. Exp Ther Med 2017 Jul;14(1):228-238
Pironkova RP et al
2017/01/01
PubMed
17 Pranzatelli MR et al. CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders. J. Neuroimmunol. 2014 Jan;266(1-2):75-81
Pranzatelli MR et al
2014/01/01
PubMed
18 Qiao X et al. Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, is Associated With Peripheral Neuropathy in Patients With Type 2 Diabetes. Medicine (Baltimore) 2015 Nov;94(44):e1908
Qiao X et al
2015/01/01
PubMed
19 Steinacker P et al. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J. Neurol. Neurosurg. Psychiatry 2016 Jan;87(1):12-20
Steinacker P et al
2016/01/01
PubMed
20 Sumitani M et al. Poor efficacy of the phosphorylated high-molecular-weight neurofilament heavy subunit serum level, a biomarker of axonal damage, as a marker of chemotherapy-induced peripheral neuropathy. Biomed Rep 2016 Jun;4(6):758-760
Sumitani M et al
2016/01/01
PubMed
21 Takahashi H et al. Phosphorylated neurofilament subunit NF-H becomes elevated in the cerebrospinal fluid of patients with acutely worsening symptoms of compression myelopathy. J Clin Neurosci 2014 Dec;21(12):2175-8
Takahashi H et al
2014/01/01
PubMed
22 Vajtr D et al. Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuries. Soud Lek 2012 Jan;57(1):7-12
Vajtr D et al
2012/01/01
PubMed
23 Yang Z et al. Temporal Profile and Severity Correlation of a Panel of Rat Spinal Cord Injury Protein Biomarkers. Mol. Neurobiol. 2018 03;55(3):2174-2184
Yang Z et al
2018/01/01
PubMed
24 Yokobori S et al. Quantitative pupillometry and neuron-specific enolase independently predict return of spontaneous circulation following cardiogenic out-of-hospital cardiac arrest: a prospective pilot study. Sci Rep 2018 Oct;8(1):15964
Yokobori S et al
2018/01/01
PubMed
25 貼urek J et al. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien) 2012 Jan;154(1):93-103; discussion 103
貼urek J et al
2012/01/01
PubMed
26 Sacktor N et al. Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial. J. Neurovirol. 2018 02;24(1):16-27
Sacktor N et al
2018/01/01
PubMed
27 Singh A et al. Phosphorylated neurofilament heavy: A potential blood biomarker to evaluate the severity of acute spinal cord injuries in adults. Int J Crit Illn Inj Sci ;7(4):212-217
Singh A et al
PubMed
28 Sandsmark DK et al. Changes in Plasma von Willebrand Factor and Cellular Fibronectin in MRI-Defined Traumatic Microvascular Injury. Front Neurol 2019;10:246
Sandsmark DK et al
2019/01/01
PubMed
29 Wurster CD et al. Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment. Ther Adv Neurol Disord 2019;12:1756286419846058
Wurster CD et al
2019/01/01
PubMed
  • No.: 1
  • 文献情報:
    Zurek J et al. Hyperphosphorylated neurofilament NF-H as a predictor of mortality after brain injury in children. Brain Inj 2011;25(2):221-6
    Zurek J et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Cai JY et al. Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage. Clin. Chim. Acta 2013 Sep;424:182-6
    Cai JY et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Chen X et al. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis. BMC Neurol 2016 Sep;16:173
    Chen X et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Denk J et al. Specific serum and CSF microRNA profiles distinguish sporadic behavioural variant of frontotemporal dementia compared with Alzheimer patients and cognitively healthy controls. PLoS ONE 2018;13(5):e0197329
    Denk J et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Fialov叩 L et al. Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis. J. Neuroimmunol. 2013 Jun;259(1-2):81-7
    Fialov叩 L et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Ganesalingam J et al. Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J. Neurochem. 2011 May;117(3):528-37
    Ganesalingam J et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Gon巽alves M et al. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis. Clin. Chim. Acta 2015 Jan;438:342-9
    Gon巽alves M et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Gresle MM et al. Neurofilament proteins as body fluid biomarkers of neurodegeneration in multiple sclerosis. Mult Scler Int 2011;2011:315406
    Gresle MM et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Inoue R et al. Direct evidence of central nervous system axonal damage in patients with postoperative delirium: A preliminary study of pNF-H as a promising serum biomarker. Neurosci. Lett. 2017 Jul;653:39-44
    Inoue R et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Kuwajima K et al. Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study. PLoS ONE 2018;13(11):e0207310
    Kuwajima K et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Lehmer C et al. Poly-GP in cerebrospinal fluid links <i>C9orf72</i>-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD. EMBO Mol Med 2017 07;9(7):859-868
    Lehmer C et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Li S et al. Phosphorylated neurofilament heavy chain levels in paired plasma and CSF of amyotrophic lateral sclerosis. J. Neurol. Sci. 2016 Aug;367:269-74
    Li S et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    McGuire JL et al. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders. J. Neurovirol. 2015 Aug;21(4):439-48
    McGuire JL et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Natori A et al. Potential role of pNF-H, a biomarker of axonal damage in the central nervous system, as a predictive marker of chemotherapy-induced cognitive impairment. Clin. Cancer Res. 2015 Mar;21(6):1348-52
    Natori A et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Pawliszak W et al. Three-vessel coronary artery disease may predict changes in biochemical brain injury markers after off-pump coronary artery bypass grafting<sup></sup>. J Zhejiang Univ Sci B ;19(9):735-738
    Pawliszak W et al
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Pironkova RP et al. Brain injury with systemic inflammation in newborns with congenital heart disease undergoing heart surgery. Exp Ther Med 2017 Jul;14(1):228-238
    Pironkova RP et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Pranzatelli MR et al. CSF neurofilament light chain is elevated in OMS (decreasing with immunotherapy) and other pediatric neuroinflammatory disorders. J. Neuroimmunol. 2014 Jan;266(1-2):75-81
    Pranzatelli MR et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Qiao X et al. Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, is Associated With Peripheral Neuropathy in Patients With Type 2 Diabetes. Medicine (Baltimore) 2015 Nov;94(44):e1908
    Qiao X et al
    2015/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Steinacker P et al. Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients. J. Neurol. Neurosurg. Psychiatry 2016 Jan;87(1):12-20
    Steinacker P et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Sumitani M et al. Poor efficacy of the phosphorylated high-molecular-weight neurofilament heavy subunit serum level, a biomarker of axonal damage, as a marker of chemotherapy-induced peripheral neuropathy. Biomed Rep 2016 Jun;4(6):758-760
    Sumitani M et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Takahashi H et al. Phosphorylated neurofilament subunit NF-H becomes elevated in the cerebrospinal fluid of patients with acutely worsening symptoms of compression myelopathy. J Clin Neurosci 2014 Dec;21(12):2175-8
    Takahashi H et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Vajtr D et al. Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuries. Soud Lek 2012 Jan;57(1):7-12
    Vajtr D et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Yang Z et al. Temporal Profile and Severity Correlation of a Panel of Rat Spinal Cord Injury Protein Biomarkers. Mol. Neurobiol. 2018 03;55(3):2174-2184
    Yang Z et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Yokobori S et al. Quantitative pupillometry and neuron-specific enolase independently predict return of spontaneous circulation following cardiogenic out-of-hospital cardiac arrest: a prospective pilot study. Sci Rep 2018 Oct;8(1):15964
    Yokobori S et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    貼urek J et al. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien) 2012 Jan;154(1):93-103; discussion 103
    貼urek J et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Sacktor N et al. Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial. J. Neurovirol. 2018 02;24(1):16-27
    Sacktor N et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Singh A et al. Phosphorylated neurofilament heavy: A potential blood biomarker to evaluate the severity of acute spinal cord injuries in adults. Int J Crit Illn Inj Sci ;7(4):212-217
    Singh A et al
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Sandsmark DK et al. Changes in Plasma von Willebrand Factor and Cellular Fibronectin in MRI-Defined Traumatic Microvascular Injury. Front Neurol 2019;10:246
    Sandsmark DK et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Wurster CD et al. Neurochemical markers in CSF of adolescent and adult SMA patients undergoing nusinersen treatment. Ther Adv Neurol Disord 2019;12:1756286419846058
    Wurster CD et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed